At a glance
- Originator Roche
- Developer Nonindustrial source; Roche
- Class
- Mechanism of Action Endothelin A receptor antagonists; Endothelin B receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Coronary disorders; Peptic ulcer; Ulcerative colitis
Most Recent Events
- 06 Jan 2003 No development reported - Preclinical for Coronary disorders in USA (PO)
- 06 Jan 2003 No development reported - Preclinical for Peptic ulcer in Switzerland (PO)
- 06 Jan 2003 No development reported - Preclinical for Ulcerative colitis in Canada (PO)